Table 1.

Sample set summary.

Number of cases
Primary Tumor SiteTotalTrainingValidationGroupSurvival range (mo)Median survival (mo)
Tongue211Head and Neck (12)2–9844.5
Thyroid844
Larynx11
Thymus11
Kidney291311Urogenital (36)0–8426.5
Uterus514
Prostate22
Bladder522
Ovary11
Colon752Gastrointestinal (15)1–788
Liver523
Gastroenteric211
Rectum11
Breast1266Breast (12)3–7136
Lung251112Lung (23)2–397
Melanoma743Melanoma (7)4–427
Unknown Carcinoma2088Unknown (16)1–625.5
Sarcoma261111Sarcoma (22)2–4224
Total Cases1597271Total (143)0–9815
Survival Range (months)1–830–98
Median Survival (months)1810

NOTE: List of the primary tumor for each bone metastasis sample in the study set. Composition of the training and validation sets with samples randomly chosen from the group of 143 samples with known survival data following first bone metastasis diagnosis and number of samples for each primary tumor group. Composition of the 8 groups based on the primary tumor origin. The number of cases, survival range and median of survivals are indicated for each group. Complete clinical data (age, sex, primary tumor site, survival, number of bone, and total metastases) are provided in Supplementary Table S1.